Tagged Articles

Subsys 19 articles

Billionaire drug maker pleads not guilty to opioid bribery scheme

John Kapoor, the billionaire founder of the Arizona-based drug company Insys Therapeutics Inc., pleaded not guilty to charges he participated in a scheme to pay kickbacks to doctors to push sales of the company’s potent fentanyl spray, Subsys. Last month, Kapoor resigned from the company’s board of directors following the resignation of Insys’s majority shareholder and chief executive officer, who was charged with engaging in conspiracies to commit racketeering, mail fraud and wire fraud. Board member Patrick Fourteau also resigned citing personal reasons. Six former Insys executives and managers face similar charges – Michael Babich, Alec Burlakoff, Michael J. Gurry, Richard ... Read More

Insys founder resigns from board amid opioid scandal

The billionaire founder of Arizona-based Insys Therapeutics, John Kapoor, has resigned from the company’s board of directors following his arrest on charges he participated in a scheme to bribe doctors and mislead health insurance companies in an effort to boost sales of the company’s powerful opioid painkiller Subsys. Subsys is a highly potent, fentanyl-based spray that is only intended for breakthrough pain in cancer patients. Kapoor, Insys’ majority shareholder, resigned as chief executive officer in January after being charged with engaging in conspiracies to commit racketeering, mail fraud and wire fraud. Board members Patrick Fourteau, also resigned citing personal reasons. ... Read More

Insys founder arrested, charged with racketeering, fraud

The founder and chairman of a pharmaceutical company accused of using unscrupulous practices to push sales of its highly addictive cancer treatment to patients without cancer was arrested and charged with racketeering and fraud. John Kapoor joins six other Insys Therapeutics Inc. officials who have been charged in a scheme to bribe medical professionals to prescribe Subsys, a highly potent, fentanyl-based spray only intended for breakthrough pain in cancer patients. Kapoor is scheduled to appear in a Massachusetts federal court on Nov. 16. “In the midst of a nationwide opioid epidemic that has reached crisis proportions, Mr. Kapoor and his ... Read More

New Jersey Accuses Insys of ‘Evil’ Campaign to Boost Opioid Sales

The State of New Jersey is suing the drugmaker Insys Therapeutics in Middlesex County Superior Court, alleging the company engaged in a reckless “greed driven” campaign to boost sales of its potent and highly addictive opioid painkiller Subsys. New Jersey’s Division of Consumer Affairs, part of the state’s Department of Law and Public Safety, filed the lawsuit in Middlesex County Superior Court, claiming the Arizona-based company violated the New Jersey Consumer Fraud Act and the New Jersey False Claims Act with its Subsys sales tactics. Subsys is a fentanyl-based opioid painkiller that the U.S. Food and Drug Administration (FDA) approved ... Read More

Insys facing more legal woes over marketing of fentanyl drug Subsys

Drug maker Insys Therapeutics Inc., is facing more legal woes over marketing of its fentanyl-based opioid Subsys, with a lawsuit filed by the state of New Jersey accusing the company engaged in a “greed-driven” campaign of consumer fraud and false claims to insurance carriers in an effort to boost sales of Subsys. The lawsuit was filed in Middlesex County Superior Court by New Jersey’s Division of Consumer Affairs, a branch of the state’s Division of Law and Public Safety. The complaint accuses Insys of unlawfully directing its sales reps to push Subsys prescriptions outside its narrow indication for breakthrough pain in ... Read More

Insys sues Teva for patent infringement of Subsys

Saddled with lawsuits and criminal investigations over its potent oral spray opioid Subsys, Insys Therapeutics lashed out against rival drug maker Teva Pharmaceuticals alleging Teva intends to manufacture and sell a generic version of Subsys before Insys’ patent for Subsys expires. Insys filed the patent-infringement lawsuit against Teva in federal court in Delaware. Insys hasn’t marketed any of its pharmaceuticals since 2015, after the company was slapped with lawsuits over its marketing of Subsys. Insys was accused of paying kickbacks to doctors to prescribe the drug for patients for whom it was not intended and for conning insurance companies to ... Read More

Trial date set for Insys reps over kickbacks to docs

Six former Insys Therapeutics Inc., executives and managers are headed to court Oct. 15, 2018, to face charges that they paid kickbacks to doctors to prescribe a powerful opioid painkiller spray to patients for whom the medication was not intended, and conned insurance companies to cover the cost of the expensive meds. U.S. District Judge Allison D. Burroughs set the trial date for Michael L. Babich, Alec Burlakoff, Michael J. Gurry, Richard Simon, Sunrise Lee, and Joseph A. Rowan. The trial is expected to last about 10 weeks. The drug in question is Subsys, a spray version of the painkiller ... Read More

Lawsuit: Opioid reps misled insurers, paid kickbacks to doctors

The family of 32-year-old Sarah Fuller filed a lawsuit against Insys Therapeutics last spring claiming the company paid kickbacks to physicians to prescribe its potent opioid Subsys, a spray version of fentanyl, which allegedly led the woman’s fatal overdose. A new report indicates Fuller was a tragic victim of unscrupulous practices by the drug company. Insys allegedly conned insurance companies into thinking the drug was for breakthrough pain in cancer patients – its only indication – so that the insurance companies would pay for the meds. The company not only misled insurance companies, the company’s representatives also falsified medical records and paid ... Read More

Wrongful death lawsuit targets opioid manufacturer, prescribing physician

The family of a 32-year-old woman filed a wrongful death lawsuit against Insys Therapeutics alleging the pharmaceutical company paid kickbacks to physicians who prescribed its powerful opioid fentanyl. The lawsuit was filed in Middlesex County (New Jersey) Superior Court by the parents of Sarah Fuller and names Insys Therapeutics; the deceased woman’s physician, Vivienne Matalon; Matalon’s practice TLC Healthcare 2; and Linden Care of Woodbury, New York, the specialty pharmacy that filled Fuller’s prescription. The complaint alleges that Fuller went to see Matalon for fibromyalgia and back pain, during which an Insys sales representative joined them to allegedly convince Fuller ... Read More